Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-52,321
Closed -$2.56M 1612
2026
Q1
$2.56M Sell
52,321
-144,541
-73% -$7.59M 0.02% 673
2025
Q4
$10.4M Buy
+196,862
New +$11.5M 0.08% 250
2025
Q1
Sell
-42,012
Closed -$1.47M 1507
2024
Q4
$1.47M Buy
42,012
+20,121
+92% +$708K 0.01% 825
2024
Q3
$849K Buy
+21,891
New +$804K 0.01% 1014
2024
Q1
Sell
-4,621
Closed -$202K 1516
2023
Q4
$202K Buy
+4,621
New +$185K ﹤0.01% 1276
2023
Q3
Sell
-33,402
Closed -$1.67M 1737
2023
Q2
$1.67M Sell
33,402
-15,730
-32% -$758K 0.01% 887
2023
Q1
$2.63M Buy
+49,132
New +$2.68M 0.02% 770
2022
Q1
Sell
-27,732
Closed -$2.22M 2221
2021
Q4
$2.22M Sell
27,732
-55,451
-67% -$3.62M 0.02% 717
2021
Q3
$4.11M Buy
83,183
+40,540
+95% +$1.87M 0.06% 469
2021
Q2
$2.03M Sell
42,643
-77,265
-64% -$3.39M 0.02% 674
2021
Q1
$4.16M Buy
119,908
+79,755
+199% +$2.95M 0.06% 336
2020
Q4
$1.2M Sell
40,153
-12,768
-24% -$315K 0.01% 766
2020
Q3
$941K Buy
+52,921
New +$999K 0.02% 709

Other funds holding CALX

Michael Gelband's CALX Position: Q2 2026 in Review

Michael Gelband sold out of Calix (CALX) in Q2 2026, closing a stake of 52,321 shares — an estimated $2.56M sold.

Michael Gelband first reported a position in CALX in Q3 2020 and held it in 13 quarters. The position peaked at $10.4M in Q4 2025. 285 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Michael Gelband reported no remaining Calix position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 52,321 Calix shares in Q2 2026, an estimated $2.56M.
  • Michael Gelband first reported a position in Calix in Q3 2020 and held it in 13 quarters.
  • Michael Gelband's Calix position peaked at $10.4M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.